Georgiamune
PrivateLast Round
Series B
Aug 17, 2026
Total Funding Raised
$79.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Georgiamune is a biotechnology company that develops immunotherapies aimed at reprogramming immune signaling pathways to treat cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Georgiamune Comparables
Compare Georgiamune with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoGenesis | 86% | |
| Immune-Onc Therapeutics | 85% | |
| OncoC4, Inc. | 84% | |
Georgiamune Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 17, 2026 | ||||
| Series A | Aug 9, 2023 |
Georgiamune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Parker Institute for Cancer Immunotherapy | Series A |
| Catalio Capital Management | Series A |
| General Catalyst | Series A |
| Mubadala Capital | Series A |
| Alexandria Venture Investments | Series A |
| CJNV BioVenture | Series A |
| Verition Fund Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 17, 2026
$93M round completed.
- Jul 26, 2026
Monthly visitors increased 139% MoM, reaching 2.6K.
Georgiamune Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Georgiamune's valuation, stock price, and market status.